Johnson & Johnson Non-GAAP EPS of $2.46 in-line, revenue of $24.6B beats by $440M

Adjusted Operational Sales^1,2

Change vs. Prior Year / Mid-point

5.4% – 6.4% / 5.9%

Operational Sales² / Mid-point

Change vs. Prior Year / Mid-point

$99.5B – $100.5B / $100.0B

5.7% – 6.7% / 6.2%

Estimated Reported Sales³/ Mid-point

Change vs. Prior Year / Mid-point

$100.0B – $101.0B / $100.5B

6.2% – 7.2% / 6.7%

Adjusted Operational EPS (Diluted)^2,4 / Mid-point

Change vs. Prior Year / Mid-point

$11.28 – $11.48 / $11.38

4.5% – 6.5% / 5.5%

Adjusted EPS (Diluted)^3,4 / Mid-point

Change vs. Prior Year / Mid-point

$11.43 – $11.63 / $11.53

5.9% – 7.9% / 6.9%